Extrapyramidal side effects with nonantipsychotic medications. [PDF]
Koch J, Launio M, Williams AM.
europepmc +1 more source
Pregnenolone Reduces L-Dopa-Induced Dyskinesias in Female Parkinsonian Monkeys. [PDF]
Bourque M +5 more
europepmc +1 more source
Disease-modifying effect, safety and optimal dose of oral semaglutide tablets for patients with Parkinson's disease (MOST-ABLE study): protocol for a randomised, double-blind, placebo-controlled study. [PDF]
Kimura Y +15 more
europepmc +1 more source
AI-Driven Analysis of Wrist-Worn Sensor Data for Monitoring Individual Treatment Response and Optimizing Levodopa Dosing in Parkinson's Disease. [PDF]
Sander M +4 more
europepmc +1 more source
Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment. [PDF]
Poleur M +8 more
europepmc +1 more source
Central Nervous System-Active Medications and Risk of Hospital Readmission in Older Multimorbid Adults. [PDF]
Stuber MJ +10 more
europepmc +1 more source
Sex and Diet Biased Effect of L-DOPA on Iron Accumulation in the Ventral Midbrain. [PDF]
Serpa RO +6 more
europepmc +1 more source
Scoping Review of Treatment Strategies for Holmes Tremor: Pharmacological and Surgical Interventions. [PDF]
Chung G, Ferraz HB.
europepmc +1 more source
Symptom improvement in a South Asian patient with Parkinson's disease treated with immediate- and extended-release carbidopa-levodopa: a case report. [PDF]
Reiner G, Skipworth M.
europepmc +1 more source
Immunglobuline unter antiepileptischer Langzeitmedikation [PDF]
Berlit, Peter +6 more
core +1 more source

